Regulation of immune cell function by short-chain fatty acids.

Corrêa-Oliveira R, Fachi JL, Vieira A, Sato FT, Vinolo MA. · 2016

Read Regulation of immune cell function by short-chain fatty acids. by Corrêa-Oliveira R, Fachi JL, Vieira A, Sato FT, Vinolo MA. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4855267.txt.

Introduction

Renan Corrêa-Oliveira and co-authors reviewed in 2016 how short-chain fatty acids steer immune cells. Gut bacteria ferment fiber into these small fats, chiefly acetate, propionate, and butyrate, named for their two, three, and four carbon chains. Gut lining cells burn some for fuel. The rest act as signals between microbes and the immune system.

The fats switch on surface receptors on gut and immune cells and also tweak gene-control marks inside them. Through those routes they shape cell growth, survival, and action across many immune types. The review pulls the routes together, showing how a food breakdown product helps set gut peace and defense.

Catalog record

CREATORCorrêa-Oliveira R, Fachi JL, Vieira A, Sato FT, Vinolo MA.
YEAR2016
COLLECTIONPAPERS
FORMATTXT
FILE SIZE49 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4855267

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Regulation of immune cell function by short-chain fatty acids By Renan Corrêa-Oliveira, José Luís Fachi, Aline Vieira, Fabio Takeo Sato, Marco Aurélio R Vinolo Published in: Clinical & Translational Immunology DOI: 10.1038/cti.2016.17 ABSTRACT Short-chain fatty acids (SCFAs) are bacterial fermentation products, which are chemically composed by a carboxylic acid moiety and a small hydrocarbon chain. Among them, acetic, propionic and butyric acids are the most studied, presenting, respectively, two, three and four carbons in their chemical structure. These metabolites are found in high concentrations in the intestinal tract, from where they are uptaken by intestinal epithelial cells (IECs). The SCFAs are partially used as a source of ATP by these cells. In addition, these molecules act as a link between the microbiota and the immune system by modulating different aspects of IECs and leukocytes development, survival and function through activation of G protein coupled receptors (FFAR2, FFAR3, GPR109a and Olfr78) and by modulation of the activity of enzymes and transcription factors including the histone acetyltransferase and deacetylase and the hypoxia-inducible factor. Considering that, it is not a surprise, the fact that these molecules and/or their targets are suggested to have an important role in the maintenance of intestinal homeostasis and that changes in components of this system are associated with pathological conditions including inflammatory bowel disease, obesity and others. The aim of this review is to present a clear and updated description of the effects of the SCFAs derived from bacteria on host immune system, as well as the molecular mechanisms involved on them. Colonization of the skin, oral cavity, gastrointestinal, genital and respiratory tracts by bacteria, viruses and fungi, microorganims collectively referred as microbiota, is important for the proper functioning of several physiological processes including host tissues development, nutrient absorption and metabolism.1, 2 Microbiota–host interaction is also essential for the proper function of the immune system. The development of immune cells, production of effector soluble molecules such as antibodies, antimicrobial peptides and the function of several components of host defense are modulated by the microbiota.3 Taking this into account, it is not surprising that the loss of this balance between host immune system and microbiota components is associated with the development of infections and inflammatory diseases such as periodontal disease, bacterial vaginosis, inflammatory bowel disease, rheumatoid arthritis and obesity.4, 5, 6 Despite the advances in this field, the molecular mechanisms that account for the interaction microbiota-immune system are not completely understood. Microbial-associated molecular patterns including lipopolysaccharide and peptidoglycans, metabolic molecules including lactic acid and short-chain fatty acids (SCFAs), ATP and others were described to play a role in this context.3, 7, 8 However, it has been arduous to establish a relation between microbiota-derived molecules, their host molecular targets and effects on normal and pathological conditions since, among other factors, it is difficult to distinguish their individual contribution to this multicomponent and complex system. One class of molecules that acts as a link between the microbiota and the immune system is the SCFAs. These are bacterial fermentation products, which are chemically composed by a carboxylic acid moiety and a small hydrocarbon chain. The most common and most studied of them are acetic, propionic and butyric acids, which have, respectively, two, three and four carbons in their chemical structure. The SCFAs are found in high concentrations in the intestinal tract, where there is a dense population of bacteria that metabolizes indigestible saccharides and, to a lesser extend other molecules, and release the SCFAs as end products of the fermentation process. Concentrations ranging from 70 to 140 mm in proximal colon and 20 to 70 mm in the distal colon have been described for the SCFAs with a predominance of acetate in comparison to the other SCFAs.9 In addition, SCFAs are also present in the oral cavity (from 6 to 38 mm of acetate, 1 to 13 mm of propionate and 0 to 5 mm of butyrate) and female genital tract (acetate concentrations may reach 120 mm in the lower genital tract), where their concentrations vary depending on the presence or not of infection/inflammation.10, 11 The SCFAs are known to modify several cellular processes including gene expression, chemotaxis, differentiation, proliferation and apoptosis. Signaling pathways such as activation of G protein coupled receptors (GPCRs), inhibition of histone deacetylases (HDACs) and stimulation of histone acetyltransferase activity, among other pathways including the recently described stabilization of the hypoxia-inducible factor (HIF) are implicated in their effects (Figure 1).12, 13, 14, 15 SCFAs activate at least four different GPCRs: the free fatty acid receptors (FFAR)-2 and -3, which are also known as GPR43 and GPR41, respectively, the niacin/butyrate receptor GPR109a (also known as HCA2) and the olfatory receptor (Olfr)-78.16, 17 These receptors show distinct patterns of expression and they have been partially associated with the effects of the SCFAs on leukocytes and intestinal epithelial cells (IECs), as described at the next sections. More details on the molecular mechanisms and on the effects of SCFAs in other tissues can be found in different reviews at the literature.14, 18 Our aim with this review is to present a clear and updated description of the effects of the SCFAs derived from bacteria on host tissues, as well as the molecular mechanisms involved on them. For this, we used mainly studies published in the last 5 years and focused in the interaction between these molecules and immune cells. SCFAS INTERACTIONS WITH INNATE MECHANISMS OF DEFENSE The epithelial barriers and the components of innate immune system are important mechanisms of defense against infection. They act with the aim of blocking the entrance of microorganisms and, once they invade the body, rapidly responding to them. In addition, these mechanisms are regulated by adaptive immune components and constitute an essential effector mechanism of this other branch of the immune system.19 EPITHELIAL CELLS The epithelial barrier is part of the host defense against microorganisms.19 Epithelial cells not only constitute a physical barrier to the entrance of microorganisms, but they are also an active component of the host defense by sensing pathogenic microorganisms or their molecules such as toxins, and responding to them, as shown for IECs.19 These cells are source of mucin and antimicrobial peptides that are secreted to the intestinal lumen, as well as immune mediators including cytokines and chemokines, which recruit and regulate the differentiation and activation of immune cells.19 As previously described, SCFAs are found in high concentrations in the intestine, where they are in close contact with the IECs. These cells uptake SCFAs through passive (mainly, the non-ionized form) and active mechanisms. Transporters such as the monocarboxylate transporter-1 (Slc16a1) and the sodium-dependent monocarboxylate transporter-1 (Slc5a8) are part of these latter mechanisms responsible for the passage of these bacterial metabolites from the intestinal lumen to the cytosol of IECs, where they are partially used as a source of ATP.18 In this context, IECs metabolize most of the absorbed butyrate, while propionate is largely taken up by the liver and acetate reaches the systemic circulation at higher concentrations.18 The relevance of SCFAs as energy supply for the colonic epithelium has been demonstrated in different studies. Donohoe et al.20 exemplifies this concept. These authors showed that colonocytes from germ-free mice present an energy-deprived state and that after their colonization with butyrate-producing bacteria in vivo

Read the complete text